A method for the treatment or prevention of coronary graft...

Details A method for the treatment or prevention of coronary graft... A method for the treatment or prevention of coronary graft...

A - Human Necessities

61

K

A61K 31/50 (2006.01) A61P 9/14 (2006.01)

Patent

CA 2376930

Levosimendan, or (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3- pyridazinyl)phenyl]hydrazono]-propanedinitrile, which has been previously suggested for the treatment of congestive heart failure is useful in the treatment or prevention of coronary graft vasospasm after coronary artery by-pass surgery.

L'invention concerne levosimendan, ou (-)-[[4-(1,4,5,6-tétrahydro-4-méthyl-6-oxo-3-pyridazinyl)phényl]hydrazono]-propanedinitrile, qui a été précédemment conseillé pour le traitement de l'insuffisance cardiaque globale. Ce produit convient pour le traitement ou la prévention du spasme vasculaire résultant d'une intervention de pontage aortocoronarien par greffe.

Affiliated with

Also associated with

Rating

A method for the treatment or prevention of coronary graft... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with A method for the treatment or prevention of coronary graft..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A method for the treatment or prevention of coronary graft... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1449898